OPM Biosciences is a comprehensive provider of cell culture media solutions and services, offering a wide range of catalog and customized options to meet the unique needs of its customers. In addition to its diverse product offerings, OPM also offers end-to-end Contract Development and Manufacturing Organization (CDMO) services for biologics, supporting biopharmaceutical companies throughout the entire drug development and manufacturing process to drive down the costs associated with new therapeutics. Established in 2013 and headquartered in Shanghai, China, OPM Biosciences has a dedicated R&D and technical support team in Pleasanton, CA.
OPM Biosciences has rapidly emerged as a premier brand in China’s cell culture media and CDMO landscape. Its CDMO services encompass the entire biologics development lifecycle, from DNA to the submission of Investigational New Drug (IND) and Biologics License Application (BLA) filings, utilizing state-of-the-art facilities equipped with single-use bioreactors ranging from 200L to 2000L. With a global clientele comprising over 1000 pharmaceutical, biotech, and research companies, OPM’s cell culture media or CDMO service has contributed to the advancement of over 200 molecules currently in clinical or commercial phases.
OPM has established dual GMP manufacturing facilities with a harmonized quality system to ensure the security of supply. Its cell culture media products are manufactured in strict adherence to cGMP guidelines.